Pacira BioSciences, Inc.
PCRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001396814
In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pacira BioSciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $70.6K in total
- Insiders trading
- 1
- Net value
- −$70.6K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pacira BioSciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Slonin Jonathan | Chief Medical Officer | 216,384 | Aug 18, 2026 | 7 |
| Wiggans Thomas G | Director | – | Jun 12, 2026 | 1 |
| Brege Laura | Director | 30,120 | Jun 12, 2026 | 1 |
| Riker Lauren Bullaro | Senior Vice President, Finance | 62,284 | Jun 12, 2026 | 5 |
| Yang Michael J. | Director | 19,798 | Jun 12, 2026 | 1 |
| Froimson Mark | Director | 26,541 | Jun 12, 2026 | 2 |
| Hirawat Samit | Director | 6,405 | Jun 12, 2026 | 2 |
| Christie Christopher | Director | 23,059 | Jun 12, 2026 | 1 |
| Young Alethia | Director | 17,798 | Jun 12, 2026 | 1 |
| Bigal Marcelo | Director | 17,798 | Jun 12, 2026 | 1 |
| Williams Kristen Marie | Chief Administrative Officer | 167,062 | Jun 5, 2026 | 3 |
| Cross Shawn | Chief Financial Officer | 105,341 | Apr 24, 2026 | 6 |
| Kronenfeld Mark A. | Director | 31,065 | Mar 19, 2026 | 1 |
| Lee Frank D. | Chief Executive Officer | 660,831 | Feb 13, 2026 | 3 |
| Teehan Brendan | Chief Commercial Officer | 100,934 | Feb 13, 2026 | 3 |
| Ceesay Abraham | Director | 9,039 | Sep 8, 2025 | 0 |
| Gaugler Daryl | Chief Operating Officer | 115,443 | Jan 6, 2025 | 0 |
| Hastings Paul J | Director | 12,724 | Jun 13, 2024 | 0 |
| Reinhart Charles A. III | Chief Financial Officer | 51,867 | Jun 13, 2024 | 0 |
| Pace Gary W | Director | 22,127 | Mar 8, 2024 | 0 |
| Winston Roy | Chief Medical Officer | 52,440 | Aug 4, 2023 | 0 |
| Stack David M | CEO and Chairman | 186,481 | Jun 16, 2023 | 0 |
| McLoughlin Dennis | Chief Customer Officer | 38,115 | Jun 7, 2023 | 0 |
| Reinhardt Max | President, Rest of World | 29,225 | Jun 7, 2023 | 0 |
| Ellis Ronald J. Jr. | Chief Strategy Officer | 30,909 | Jun 7, 2023 | 0 |
| Molloy Anthony | Chief Lgl & Compliance Officer | 12,877 | Jun 7, 2023 | 0 |
| Laranjeira Charles Anthony | Chief Technical Officer | 41,752 | Jun 16, 2022 | 0 |
| Greenstreet Yvonne | Director | 13,247 | Jun 8, 2022 | 0 |
| Longenecker John P PhD | Director | 18,823 | Mar 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 (view filing) | Jun 6-7 | 1 day | Ellis Ronald J. Jr.Chief Strategy Officer | SSale | −2.28K | $38.42 | −$87.4K | −6.9%30.9K after | 2 lots |
| Jun 7, 2023 (view filing) | Jun 5 | 2 days | Brege LauraDirector | SSale | −600 | $38.74 | −$23.2K | −5.9%9.55K after | 10b5-1 |
| Jun 2, 2023 (view filing) | May 31 | 2 days | Gaugler DarylChief Operating Officer | SSale | −2.50K | $39.08 | −$97.7K | −9.2%24.6K after | 10b5-1 |
| May 17, 2023 (view filing) | May 15 | 2 days | Hastings Paul JDirector | SSale | −7.00K | $41.85 | −$292.9K | −49.4%7.18K after | 10b5-1 |
| May 15, 2023 (view filing) | May 11 | 4 days | Pace Gary WDirector | SSale | −5.01K | $41.78 | −$209.5K | −3.5%139.7K after | |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Brege LauraDirector | SSale | −7.00K | $40.72 | −$285.0K | −40.8%10.1K after | 10b5-1 |
| Jan 6, 2023 (view filing) | Jan 4-5 | 2 days | Molloy AnthonyChief Lgl & Compliance Officer | SSale | −704 | $38.49 | −$27.1K | −3.5%19.4K after | 2 lots |
| Oct 11, 2022 (view filing) | Oct 7 | 4 days | Reinhardt MaxPresident, Rest of World | SSale | −1.38K | $58.00 | −$80.0K | −4.2%31.4K after | |
| Aug 5, 2022 (view filing) | Aug 3 | 2 days | Winston RoyChief Medical Officer | SSale | −476 | $55.70 | −$26.5K | −1.0%45.0K after | |
| Aug 5, 2022 (view filing) | Aug 3 | 2 days | Slonin JonathanChief Clinical Officer | SSale | −308 | $55.70 | −$17.2K | −0.8%37.1K after | |
| Jul 13, 2022 (view filing) | Jul 11 | 2 days | Hastings Paul JDirector | SSale | −533 | $56.95 | −$30.4K | −6.9%7.18K after | |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Slonin JonathanChief Clinical Officer | SSale | −924 | $57.19 | −$52.8K | −2.4%37.4K after | |
| Jun 8, 2022 (view filing) | Jun 6-8 | 2 days | Stack David MCEO and Chairman | SSale | −25.8K | $60.56 | −$1.56M | −15.3%142.3K after | 5 lots |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Winston RoyChief Medical Officer | SSale | −17.5K | $61.39 | −$1.08M | −33.3%35.2K after | 9 lots |
| Jun 8, 2022 (view filing) | Jun 6-7 | 2 days | Williams Kristen MarieChief Administrative Officer | SSale | −8.62K | $60.37 | −$520.2K | −38.7%13.7K after | 2 lots |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Slonin JonathanChief Clinical Officer | SSale | −362 | $61.37 | −$22.2K | −1.3%28.2K after | |
| Jun 8, 2022 (view filing) | Jun 8 | Same day | Slonin JonathanChief Clinical Officer | SSale | +24.8K | $0.00 | $0 | –24.8K after | Derivative |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Riker Lauren BullaroSenior Vice President, Finance | SSale | −1.15K | $61.37 | −$70.6K | −7.6%14.0K after | |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Reinhart Charles A. IIIChief Financial Officer | SSale | −2.52K | $61.37 | −$154.4K | −8.2%28.3K after | |
| Jun 8, 2022 (view filing) | Jun 6-7 | 2 days | Reinhardt MaxPresident, Rest of World | SSale | −5.25K | $61.66 | −$323.7K | −17.7%24.4K after | 2 lots |
| Jun 8, 2022 (view filing) | Jun 6-8 | 2 days | Laranjeira Charles AnthonyChief Technical Officer | SSale | −7.75K | $60.38 | −$467.9K | −23.1%25.9K after | 5 lots |
| Jun 8, 2022 (view filing) | Jun 6-7 | 2 days | Molloy AnthonyChief Lgl & Compliance Officer | SSale | −5.55K | $60.78 | −$337.4K | −31.6%12.0K after | 3 lots |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | McLoughlin DennisChief Customer Officer | SSale | −2.14K | $61.37 | −$131.3K | −6.3%31.8K after | |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Gaugler DarylChief Operating Officer | SSale | −1.11K | $61.37 | −$67.9K | −8.8%11.5K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Froimson MarkDirector | SSale | −1.00K | $59.37 | −$59.4K | −16.9%4.91K after | |
| Apr 25, 2022 (view filing) | Apr 21 | 4 days | Reinhardt MaxPresident, Rest of World | SSale | −9.82K | $73.25 | −$719.6K | −24.9%29.6K after | |
| Apr 20, 2022 (view filing) | Apr 18-20 | 2 days | Reinhardt MaxPresident, Rest of World | SSale | −28.0K | $73.27 | −$2.05M | −51.0%27.0K after | 3 lots |
| Apr 8, 2022 (view filing) | Apr 6 | 2 days | Molloy AnthonyChief Lgl & Compliance Officer | SSale | −22.5K | $76.42 | −$1.72M | −56.2%17.6K after | 3 lots |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Williams Kristen MarieChief Administrative Officer | SSale | −7.25K | $72.67 | −$527.1K | −24.6%22.3K after | |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Riker Lauren BullaroSenior Vice President, Finance | SSale | −9.30K | $71.22 | −$662.3K | −38.0%15.2K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Longenecker John P PhDDirector | SSale | −7.00K | $71.74 | −$502.2K | −27.1%18.8K after | |
| Mar 1, 2022 (view filing) | Feb 28-Mar 1 | 1 day | Pace Gary WDirector | SSale | −30.0K | $66.87 | −$2.01M | −18.8%129.5K after | 2 lots |
| Mar 1, 2022 (view filing) | Feb 16-25 | 13 daysLate | Williams Kristen MarieChief Administrative Officer | SSale | −2.06K | $67.01 | −$138.0K | −8.5%22.3K after | 3 lots |
| Feb 14, 2022 (view filing) | Feb 10 | 4 days | Williams Kristen MarieChief Administrative Officer | SSale | −800 | $65.18 | −$52.1K | −3.5%22.3K after | |
| Feb 8, 2022 (view filing) | Feb 4 | 4 days | Williams Kristen MarieChief Administrative Officer | SSale | −1.00K | $65.18 | −$65.2K | −4.3%22.3K after | |
| Jan 25, 2022 (view filing) | Jan 21 | 4 days | Williams Kristen MarieChief Administrative Officer | SSale | −200 | $65.41 | −$13.1K | −0.9%22.3K after | |
| Jan 20, 2022 (view filing) | Jan 18-19 | 2 days | Williams Kristen MarieChief Administrative Officer | SSale | −25.6K | $65.28 | −$1.67M | −53.5%22.3K after | 3 lots |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Riker Lauren BullaroSenior Vice President, Finance | SSale | −2.50K | $64.97 | −$162.4K | −14.2%15.2K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Molloy AnthonyChief Lgl & Compliance Officer | SSale | −224 | $63.55 | −$14.2K | −1.3%17.6K after | |
| Jul 30, 2021 (view filing) | Jul 28-29 | 2 days | Riker Lauren BullaroVice President, Finance | SSale | −2.50K | $60.85 | −$152.1K | −16.0%13.2K after | 2 lots |
| Jul 6, 2021 (view filing) | Jul 2 | 4 days | Reinhardt MaxPresident, Rest of World | SSale | −421 | $59.76 | −$25.2K | −2.3%17.5K after |